November 9, 2015

VentureMed's Flex Catheter Receives CE Mark Approval

November 10, 2015—VentureMed Group, Ltd. announced that it has received European CE Mark approval for its Flex Plaque Modification catheter for the treatment of peripheral artery disease. Flex is indicated for use in the superficial femoral and popliteal arteries.

According to the company, the Flex catheter is an over-the-wire, percutaneous device that delivers three dynamic linear “scores” in a single pass. The device’s tri-element design allows the operator to safely and effectively prepare any length of diseased vessel with a single catheter, in a single pass, in preparation for adjunctive therapy.

The Flex device incorporates VentureMed’s Dynamic Scoring to offer an effective and safe alternative to balloon-based scoring technology. Without the need for multiple balloon inflations, the physician can effectively treat a much wider range of vessel lengths and diameters, thereby saving time and cost, stated the company.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

November 9, 2015

VentureMed's Flex Catheter Receives CE Mark Approval

Current Issue

Keep In Touch